SMS Pharma Enters ₹50 Crore Subsidiary Loan Agreement

Date: 30th October, 2026

The company has entered into a Loan Agreement with its subsidiary, SMS Peptides Private Limited.

Lender: SMS Pharmaceuticals Limited
Borrower: SMS Peptides Private Limited (a subsidiary of the company)
Nature of Loan: Unsecured loan
Purpose: For the subsidiary's business purposes
Total Loan Amount: Up to an aggregate amount not exceeding ₹50 Crores (Rupees Fifty Crore Only)
Disbursement Structure: The amount may be provided in one or more tranches.
Date of Execution: 30th October, 2026
Outstanding Amount: Nil as of the date of this disclosure.

Shareholding: SMS Pharmaceuticals Limited holds a 99.99% stake in SMS Peptides Private Limited as of the date of the disclosure.
Relationship: The companies are related as parent and subsidiary and have common directors.
Transaction Type: This constitutes a related party transaction.
Basis of Transaction: The transaction has been conducted on an arm's length basis.

The agreement does not grant any special rights to the lender, such as the right to appoint directors, first right to share subscription, or the right to restrict changes in capital structure.
There are no disclosures regarding nominees on the board, potential conflicts of interest, or other significant terms.